ASC-话题@MedSci

#ASC#

1352篇内容 | 3998人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939170, encodeId=25cb19391e0c6, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2021: 摘要概览与展望 7| PD-1抑制剂Keytruda冲击胃癌一线疗法新进展！, objectType=article, longId=211864, objectId=907c211864e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907c211864e9, replyNumber=0, likeNumber=77, createdTime=2022-02-17, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907c211864e9, moduleTitle=ASCO 2021: 摘要概览与展望 7| PD-1抑制剂Keytruda冲击胃癌一线疗法新进展！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907c211864e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939195, encodeId=b538193919537, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=礼进生物在2021 ASCO年会上公布其CD137/4-1BB激动剂抗体LVGN6051的1期临床研究中期结果, objectType=article, longId=212351, objectId=4525212351b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4525212351b7, replyNumber=0, likeNumber=75, createdTime=2022-03-13, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4525212351b7, moduleTitle=礼进生物在2021 ASCO年会上公布其CD137/4-1BB激动剂抗体LVGN6051的1期临床研究中期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4525212351b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939208, encodeId=37611939208e3, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2021:阿特珠单抗+贝伐珠单抗联合治疗对不可切除肝癌有益, objectType=article, longId=212455, objectId=f416212455b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f416212455b8, replyNumber=0, likeNumber=71, createdTime=2022-04-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f416212455b8, moduleTitle=ASCO2021:阿特珠单抗+贝伐珠单抗联合治疗对不可切除肝癌有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f416212455b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939194, encodeId=87fd1939194f2, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2021开幕，大流行背景下癌症治疗公平性受关注, objectType=article, longId=212350, objectId=6e3f21235068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e3f21235068, replyNumber=0, likeNumber=92, createdTime=2022-04-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e3f21235068, moduleTitle=ASCO 2021开幕，大流行背景下癌症治疗公平性受关注, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e3f21235068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939263, encodeId=4692193926314, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：恩格列净对2型糖尿病患者右心室参数和功能的影响, objectType=article, longId=219696, objectId=9bf02196962f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bf02196962f, replyNumber=0, likeNumber=0, createdTime=2022-10-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bf02196962f, moduleTitle=Cardiovasc Diabetol：恩格列净对2型糖尿病患者右心室参数和功能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bf02196962f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939237, encodeId=1101193923edb, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=J Vasc Surg Venous Lymphat Disord：资讯速递｜急性静脉血栓栓塞临床研究——导管定向溶栓治疗深静脉血栓患者颅内出血的预测因子分析, objectType=article, longId=215515, objectId=0a702155156e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a702155156e, replyNumber=0, likeNumber=129, createdTime=2021-10-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a702155156e, moduleTitle=J Vasc Surg Venous Lymphat Disord：资讯速递｜急性静脉血栓栓塞临床研究——导管定向溶栓治疗深静脉血栓患者颅内出血的预测因子分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a702155156e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939245, encodeId=0cff1939245b7, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：降糖治疗对糖尿病透析患者生存预后的影响, objectType=article, longId=216876, objectId=90d12168e62b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90d12168e62b, replyNumber=0, likeNumber=78, createdTime=2022-05-12, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90d12168e62b, moduleTitle=Cardiovasc Diabetol：降糖治疗对糖尿病透析患者生存预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90d12168e62b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939147, encodeId=7c31193914ef1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO GU 2021: 达洛鲁胺治疗非转移性去势抵抗性前列腺癌疗效分析, objectType=article, longId=207265, objectId=388d20e265f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=388d20e265f5, replyNumber=0, likeNumber=74, createdTime=2021-06-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=388d20e265f5, moduleTitle=ASCO GU 2021: 达洛鲁胺治疗非转移性去势抵抗性前列腺癌疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=388d20e265f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939145, encodeId=2da319391451c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO GU 2021: ctDNA检测能有效判断Olaparib对去势抵抗性前列腺癌效果（PROfound研究）, objectType=article, longId=207230, objectId=677220e230b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=677220e230b0, replyNumber=0, likeNumber=81, createdTime=2021-06-29, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=677220e230b0, moduleTitle=ASCO GU 2021: ctDNA检测能有效判断Olaparib对去势抵抗性前列腺癌效果（PROfound研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677220e230b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939129, encodeId=23c41939129b9, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO GI 2021：帕博利珠单抗可显著改善MSI-H/dMMR mCRC患者的PFS（KEYNOTE-177研究）, objectType=article, longId=205930, objectId=92a920593034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92a920593034, replyNumber=0, likeNumber=80, createdTime=2021-04-10, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92a920593034, moduleTitle=ASCO GI 2021：帕博利珠单抗可显著改善MSI-H/dMMR mCRC患者的PFS（KEYNOTE-177研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92a920593034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939182, encodeId=d36419391823f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2021: 摘要概览与展望 16 |ctDNA在预测结直肠癌复发及全程管理中的潜在作用, objectType=article, longId=212111, objectId=4d9a21211161, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d9a21211161, replyNumber=0, likeNumber=75, createdTime=2022-05-14, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d9a21211161, moduleTitle=ASCO 2021: 摘要概览与展望 16 |ctDNA在预测结直肠癌复发及全程管理中的潜在作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d9a21211161)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939249, encodeId=3fed19392491c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Res：我们要更加关注右心衰竭-转录因子Hand2, objectType=article, longId=217623, objectId=b91c21e62336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b91c21e62336, replyNumber=0, likeNumber=79, createdTime=2021-11-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b91c21e62336, moduleTitle=Cardiovasc Res：我们要更加关注右心衰竭-转录因子Hand2, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b91c21e62336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939118, encodeId=2cb319391183a, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=JACC Cardiovasc Interv：在治疗有症状的股骨膜病变时，Zilver PTX支架似乎并不优于Misago支架——BATTLE试验1年研究结果, objectType=article, longId=203336, objectId=cf2b203336a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf2b203336a3, replyNumber=0, likeNumber=60, createdTime=2021-09-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf2b203336a3, moduleTitle=JACC Cardiovasc Interv：在治疗有症状的股骨膜病变时，Zilver PTX支架似乎并不优于Misago支架——BATTLE试验1年研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf2b203336a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939116, encodeId=5c9f1939116a4, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Intervent Radiol：两项大型研究结果表明，Zilver PTX药物洗脱支架治疗不会增加患者的长期死亡率, objectType=article, longId=203302, objectId=77e6203302d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e6203302d2, replyNumber=0, likeNumber=92, createdTime=2021-07-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e6203302d2, moduleTitle=Cardiovasc Intervent Radiol：两项大型研究结果表明，Zilver PTX药物洗脱支架治疗不会增加患者的长期死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77e6203302d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939202, encodeId=0e751939202ec, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO-2021速递: 哈佛大学:乳腺癌药物，可延长胶质母细胞瘤的无进展生存期, objectType=article, longId=212407, objectId=dc0d21240ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc0d21240ed5, replyNumber=0, likeNumber=107, createdTime=2021-11-20, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc0d21240ed5, moduleTitle=ASCO-2021速递: 哈佛大学:乳腺癌药物，可延长胶质母细胞瘤的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc0d21240ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939213, encodeId=4beb193921384, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2021:Patritumab Deruxtecan在EGFR抑制剂耐药、EGFR突变的非小细胞肺癌患者中产生持久反应, objectType=article, longId=212480, objectId=b2a22124805f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a22124805f, replyNumber=0, likeNumber=94, createdTime=2021-06-12, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a22124805f, moduleTitle=ASCO2021:Patritumab Deruxtecan在EGFR抑制剂耐药、EGFR突变的非小细胞肺癌患者中产生持久反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a22124805f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939128, encodeId=aee2193912807, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO GI 2020：dostarlimab在错配修复缺陷（dMMR）实体瘤取得积极疗效数据, objectType=article, longId=205841, objectId=b4b220584147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4b220584147, replyNumber=0, likeNumber=101, createdTime=2021-04-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4b220584147, moduleTitle=ASCO GI 2020：dostarlimab在错配修复缺陷（dMMR）实体瘤取得积极疗效数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4b220584147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939143, encodeId=0b651939143c6, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO GU 2021: 阿替利珠单抗一线治疗局晚或转移的尿路上皮癌结果发布（IMvigor130研究）, objectType=article, longId=207204, objectId=d52d20e20494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d52d20e20494, replyNumber=0, likeNumber=72, createdTime=2021-05-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d52d20e20494, moduleTitle=ASCO GU 2021: 阿替利珠单抗一线治疗局晚或转移的尿路上皮癌结果发布（IMvigor130研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d52d20e20494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939156, encodeId=80a7193915664, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物, objectType=article, longId=210669, objectId=cd6f210669ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd6f210669ad, replyNumber=0, likeNumber=74, createdTime=2021-11-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd6f210669ad, moduleTitle=Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd6f210669ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939220, encodeId=0fd319392205d, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Journal of Cardiovascular Magnetic Resonance：用定量心血管磁共振心肌灌注图表征左内乳冠状动脉搭桥术患者的心肌缺血, objectType=article, longId=212951, objectId=8df9212951c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8df9212951c4, replyNumber=0, likeNumber=107, createdTime=2022-04-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8df9212951c4, moduleTitle=Journal of Cardiovascular Magnetic Resonance：用定量心血管磁共振心肌灌注图表征左内乳冠状动脉搭桥术患者的心肌缺血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8df9212951c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2021: 摘要概览与展望 7| PD-1抑制剂Keytruda冲击胃癌一线疗法新进展！

2022-02-17

quxin068 (审核中...)

前往app查看评论内容

#ASC#

礼进生物在2021 ASCO年会上公布其CD137/4-1BB激动剂抗体LVGN6051的1期临床研究中期结果

2022-03-13

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2021:阿特珠单抗+贝伐珠单抗联合治疗对不可切除肝癌有益

2022-04-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2021开幕，大流行背景下癌症治疗公平性受关注

2022-04-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：恩格列净对2型糖尿病患者右心室参数和功能的影响

2022-10-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

J Vasc Surg Venous Lymphat Disord：资讯速递｜急性静脉血栓栓塞临床研究——导管定向溶栓治疗深静脉血栓患者颅内出血的预测因子分析

2021-10-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：降糖治疗对糖尿病透析患者生存预后的影响

2022-05-12

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO GU 2021: 达洛鲁胺治疗非转移性去势抵抗性前列腺癌疗效分析

2021-06-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO GU 2021: ctDNA检测能有效判断Olaparib对去势抵抗性前列腺癌效果（PROfound研究）

2021-06-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO GI 2021：帕博利珠单抗可显著改善MSI-H/dMMR mCRC患者的PFS（KEYNOTE-177研究）

2021-04-10

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2021: 摘要概览与展望 16 |ctDNA在预测结直肠癌复发及全程管理中的潜在作用

2022-05-14

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Res：我们要更加关注右心衰竭-转录因子Hand2

2021-11-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

JACC Cardiovasc Interv：在治疗有症状的股骨膜病变时，Zilver PTX支架似乎并不优于Misago支架——BATTLE试验1年研究结果

2021-09-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Intervent Radiol：两项大型研究结果表明，Zilver PTX药物洗脱支架治疗不会增加患者的长期死亡率

2021-07-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO-2021速递: 哈佛大学:乳腺癌药物，可延长胶质母细胞瘤的无进展生存期

2021-11-20

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2021:Patritumab Deruxtecan在EGFR抑制剂耐药、EGFR突变的非小细胞肺癌患者中产生持久反应

2021-06-12

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO GI 2020：dostarlimab在错配修复缺陷（dMMR）实体瘤取得积极疗效数据

2021-04-06

zhouqu_8 (审核中...)

前往app查看评论内容

#ASC#

ASCO GU 2021: 阿替利珠单抗一线治疗局晚或转移的尿路上皮癌结果发布（IMvigor130研究）

2021-05-25

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Br J Cancer：RNAscope技术检测α-甲胎蛋白mRNA水平为肝细胞癌的新型的高度特异性标志物

2021-11-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Journal of Cardiovascular Magnetic Resonance：用定量心血管磁共振心肌灌注图表征左内乳冠状动脉搭桥术患者的心肌缺血

2022-04-11

科室
- - 订阅+
  - 更多科室
工具
服务